These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 17902643

  • 1. Data fusion of similarity and dissimilarity measurements using Wiener-based indices for the prediction of the NPY Y5 receptor antagonist capacity of benzoxazinones.
    Ruiz IL, Urbano-Cuadrado M, Gómez-Nieto MA.
    J Chem Inf Model; 2007; 47(6):2235-41. PubMed ID: 17902643
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Refinement and use of the approximate similarity in QSAR models for benzodiazepine receptor ligands.
    Urbano Cuadrado M, Luque Ruiz I, Gómez-Nieto MA.
    J Chem Inf Model; 2006; 46(5):2022-9. PubMed ID: 16995733
    [Abstract] [Full Text] [Related]

  • 8. A preliminary study of the metabolic stability of a series of benzoxazinone derivatives as potent neuropeptide Y5 antagonists.
    Dordal A, Lipkin M, Macritchie J, Mas J, Port A, Rose S, Salgado L, Savic V, Schmidt W, Serafini MT, Spearing W, Torrens A, Yeste S.
    Bioorg Med Chem Lett; 2005 Aug 15; 15(16):3679-84. PubMed ID: 15982873
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
    Takahashi T, Sakuraba A, Hirohashi T, Shibata T, Hirose M, Haga Y, Nonoshita K, Kanno T, Ito J, Iwaasa H, Kanatani A, Fukami T, Sato N.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7501-11. PubMed ID: 16919461
    [Abstract] [Full Text] [Related]

  • 11. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
    Ogino Y, Ohtake N, Nagae Y, Matsuda K, Moriya M, Suga T, Ishikawa M, Kanesaka M, Mitobe Y, Ito J, Kanno T, Ishihara A, Iwaasa H, Ohe T, Kanatani A, Fukami T.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5010-4. PubMed ID: 18723347
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D, Adham N, Hesk D, Wu Y, Kelly J, Huang Y, Guzzi M, Zhang X, McCombie S, Stamford A, Parker E.
    Eur J Pharmacol; 2008 Dec 28; 601(1-3):1-7. PubMed ID: 18976648
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists.
    Biagetti M, Leslie CP, Mazzali A, Seri C, Pizzi DA, Bentley J, Genski T, Di Fabio R, Zonzini L, Caberlotto L.
    Bioorg Med Chem Lett; 2010 Aug 15; 20(16):4741-4. PubMed ID: 20630754
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. QSAR study of antiplatelet agents.
    Katritzky AR, Pacureanu LM, Slavov S, Dobchev DA, Karelson M.
    Bioorg Med Chem; 2006 Nov 15; 14(22):7490-500. PubMed ID: 16945540
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T, Kanatani A, Iwaasa H.
    Peptides; 2009 Aug 15; 30(8):1441-7. PubMed ID: 19481128
    [Abstract] [Full Text] [Related]

  • 19. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
    Upadhya MA, Dandekar MP, Kokare DM, Singru PS, Subhedar NK.
    Neuropeptides; 2009 Aug 15; 43(4):303-14. PubMed ID: 19556004
    [Abstract] [Full Text] [Related]

  • 20. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
    Bhisikar SM, Kokare DM, Nakhate KT, Chopde CT, Subhedar NK.
    Life Sci; 2009 Nov 18; 85(21-22):765-72. PubMed ID: 19846044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.